Correlation Between Vir Biotechnology and Krystal Biotech

Can any of the company-specific risk be diversified away by investing in both Vir Biotechnology and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vir Biotechnology and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vir Biotechnology and Krystal Biotech, you can compare the effects of market volatilities on Vir Biotechnology and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vir Biotechnology with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vir Biotechnology and Krystal Biotech.

Diversification Opportunities for Vir Biotechnology and Krystal Biotech

0.25

Correlation Coefficient

Vir Biotechnology  Krystal Biotech

Modest diversification

The 3 months correlation between Vir and Krystal is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Vir Biotechnology and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Vir Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vir Biotechnology are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Vir Biotechnology i.e., Vir Biotechnology and Krystal Biotech go up and down completely randomly.

Pair Corralation between Vir Biotechnology and Krystal Biotech

Considering the 90-day investment horizon Vir Biotechnology is expected to generate 1.81 times more return on investment than Krystal Biotech. However, Vir Biotechnology is 1.81 times more volatile than Krystal Biotech. It trades about 0.03 of its potential returns per unit of risk. Krystal Biotech is currently generating about 0.05 per unit of risk. If you would invest  778.00  in Vir Biotechnology on September 2, 2024 and sell it today you would earn a total of  18.00  from holding Vir Biotechnology or generate 2.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Vir Biotechnology  vs.  Krystal Biotech

Vir Biotechnology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady forward indicators, Vir Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Krystal Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Krystal Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Krystal Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Vir Biotechnology and Krystal Biotech

The main advantage of trading using opposite Vir Biotechnology and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vir Biotechnology position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.

The idea behind Vir Biotechnology and Krystal Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.